Improvement in Quality of Life for Osteoporosis Patients Treated with Teriparatide
Author Information
Author(s): Lau Arthur N, Ali Sammy H, Sawka Anna M, Thabane Lehana, Papaioannou Alexandra, Gafni Amiram, Adachi Jonathan D
Primary Institution: McMaster University
Hypothesis
Do osteoporosis patients treated with teriparatide experience improvement in health-related quality of life and pain symptoms after several months of therapy?
Conclusion
Teriparatide use may be associated with improvements in health-related quality of life in osteoporosis patients, particularly in alleviating pain symptoms.
Supporting Evidence
- 57 patients were included in the study, with significant improvements in pain symptoms observed.
- 44% of individuals were taking pain medications before therapy, which decreased to 26% after treatment.
- Improvements were particularly noted in patients with prior vertebral fractures.
Takeaway
This study found that patients with osteoporosis who took teriparatide felt less pain and had a better quality of life after treatment.
Methodology
The study retrospectively analyzed osteoporosis patients treated with teriparatide, comparing baseline and follow-up quality of life data using a paired Student's t-test.
Potential Biases
The study may have selection bias due to its retrospective nature and lack of randomization.
Limitations
The study lacked a control group and had missing data resulting in exclusion of some participants.
Participant Demographics
The sample included 57 patients, 82.5% female, with a mean age of 63.8 years.
Statistical Information
P-Value
p = 0.019 for emotional functioning improvement, p = 0.036 for activities of daily living, p = 0.012 for leisure.
Confidence Interval
95% CI 0.61 to 0.87 for reduction in back pain.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website